About VAV Life Sciences
VAV Life Sciences is a Healthcare company based in Mumbai (India) founded in 2003. It operates as a manufacturer of phospholipids and lecithins for pharmaceutical, nutrition, and cosmetic applications. Its Indian entity Vav Life Sciences Private Limited reported revenue of ₹20.87 Cr. VAV Life Sciences offers products and services including Phospholipids and Synthetic Phospholipids. Its focus areas include Pharmaceuticals, Drug Manufacturing, Lipid Production and Nutrition and Cosmetics.
Company details
VAV Life Sciences is identified as a manufacturer of phospholipids and lecithins derived from natural and synthetic sources, which are applied in pharmaceutical, nutritional, and cosmetic sectors. Products are produced in GMP-certified facilities that comply with global pharmacopoeias, ensuring consistent quality through rigorous controls. Technical support is provided for formulation and stability, while research efforts lead to innovative processes and patents. The company is based in Mumbai, India, and serves international markets with lipids for health-related applications.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Social LinkedIn X YouTube
- Legal Name Vav Life Sciences Private Limited
- Date of Incorporation 16 Jan, 2003
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹20.87 Cr
FY 2025 · -3% YoY
- Net Profit₹1.28 Cr
FY 2025 · 6% margin
- EBITDA₹3.75 Cr
FY 2025 · 18% margin
Associated legal entities of VAV Life Sciences
VAV Life Sciences operates through Vav Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vav Life Sciences Private Limited CIN U24230MH2003PTC138713 | Active | 16 Jan 2003 | Mumbai, Maharashtra | ₹20.9 Cr | – | 2 | View details |
Products & Services of VAV Life Sciences
VAV Life Sciences offers a comprehensive portfolio of products and services, including Phospholipids and Synthetic Phospholipids.
Phospholipids from natural sources such as soybean, sunflower, and egg are produced for pharmaceutical, nutrition, and cosmetic uses.
Synthetic variants like Phosphatidylcholines and Phosphatidylglycerols are manufactured for drug delivery and other applications.
Apps and channels of VAV Life Sciences
its YouTube channel VAV Lipids P. Ltd. has 293 subscribers and 8 videos.
Videos from VAV Life Sciences
The most watched videos on VAV Life Sciences's YouTube channel, VAV Lipids P. Ltd. (293 subscribers). Click a video to play it here.
More on VAV Lipids P. Ltd..
Board of directors of Vav Life Sciences Private Limited (VAV Life Sciences)
Vav Life Sciences Private Limited is the primary company behind VAV Life Sciences. The board of Vav Life Sciences Private Limited currently have 2 directors; the longest-serving is Arun Radheshyam Kedia, appointed in 2003. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arun Radheshyam Kedia DIN 00235581 | Director | 16 Jan 2003 | 23 yrs 9 mo | Vav Life Sciences Private Limited |
| Sabita Kedia DIN 00552187 | Director | 29 Jul 2006 | 20 yrs 2 mo | Vav Life Sciences Private Limited |
Financials of VAV Life Sciences
Figures of Vav Life Sciences Private Limited, the primary company behind VAV Life Sciences, for FY 2025. Revenue was ₹20.87 Cr (-3% year on year). Net profit was ₹1.28 Cr (6% margin). EBITDA was ₹3.75 Cr (18% margin). Revenue has grown at a compounded annual rate of +17% over three years and +28% over five years.
- ₹20.87 CrRevenue · FY 2025 · -3% YoY
- ₹1.28 CrNet profit · 6% margin
- ₹3.75 CrEBITDA · 18% margin
- ₹1.20 CrPaid-up capital
- +17%Revenue CAGR, 3 years
- +28%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vav Life Sciences Private Limited are on its company page.
Detailed financial statements for VAV Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of VAV Life Sciences
The website of VAV Life Sciences (vav.in) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 8.1% vs previous month
Websites whose visitors overlap most with VAV Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| crodapharma.com | 100% | – | #1,182,931 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as VAV Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vav Life Sciences
Complete news archive for VAV Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VAV Life Sciences
VAV Life Sciences was founded in 2003.
VAV Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind VAV Life Sciences, Vav Life Sciences Private Limited, reported revenue of ₹20.87 Cr for FY 2025, down 3% year on year.
VAV Life Sciences is identified as a manufacturer of phospholipids and lecithins derived from natural and synthetic sources, which are applied in pharmaceutical, nutritional, and cosmetic sectors. Products are produced in GMP-certified facilities that comply with global pharmacopoeias, ensuring consistent quality through rigorous controls. Technical support is provided for formulation and stability, while research efforts lead to innovative processes and patents. The company is based in Mumbai, India, and serves international markets with lipids for health-related applications.
VAV Life Sciences offers Phospholipids and Synthetic Phospholipids.
VAV Life Sciences operates through Vav Life Sciences Private Limited.
The legal entities of VAV Life Sciences currently have 2 directors, including Arun Radheshyam Kedia, Sabita Kedia.